What You Should Know: - Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement. - This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer
What You Should Know: - Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer. - This partnership combines Absci's cutting-edge Integrated Drug Creation™ platform with AstraZeneca's oncology expertise, aiming to accelerate the discovery of a potential new cancer treatment. Absci's AI Engine Takes the Lead Absci will leverage
Read More
Guardant Health, Flatiron Health Integrate Genomic Profiling Tests into OncoEMR® Platform
Georgiamune and Verily Partner to Advance Novel Cancer Treatment
What You Should Know: - Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer. - Through this partnership, Verily and Georgimune will focus on identifying the patient population that could potentially benefit the most from Georgiamune’s GIM-122, a first-in-class dual-functioning antibody that has the potential to help patients with
Read More
Penn Medicine Taps Flatiron Health for Advanced Cancer Care
What You Should Know: Flatiron Health today announced a new agreement to bring Flatiron Assist™ advanced cancer care insights to oncology care clinicians at Penn Medicine’s Abramson Cancer Center (ACC).The collaboration between Flatiron Health and Penn Medicine will focus on further enabling clinicians at ACC to determine and promote site-preferred pathways and open clinical trials at the point of care alongside the NCCN Clinical Practice Guidelines in Oncology (NCCN
Read More
Pangea, FibroFighters Partner to Advance Rare Liver Cancer Treatment
What You Should Know: Pangea Biomed, the startup behind the innovative treatment response predictor, ENLIGHT, today announced its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.Fibrolamellar carcinoma (FLC) is a rare liver cancer that typically presents in young adolescents and young adults at a median age of 22 who have no history of liver disease. There is no clear standard of care for the disease, and in
Read More
FDA Selects Ontada to Investigate Rare Cancers Treated in US Community Oncology Setting
What You Should Know: Ontada, announced it was awarded a competitive contract with the U.S. Food and Drug Administration (FDA) to advance the use of real-world data (RWD) in the U.S. community oncology setting.Ontada will conduct real-world research (RWR) that aims to strengthen the scientific understanding of the natural history of rare cancers by leveraging Ontada’s community oncology footprint and unique RWD. Study Goals & Objectives The goal of the study is to
Read More
Ibex Medical Analytics Raises $55M to Drive AI for Cancer Diagnosis Adoption Globally
What You Should Know: – Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North. - The round also included participation from Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100M since Ibex’s inception in 2016.
Read More
Oncology Software: The Digital Backbone of Cancer Care
The complex and dynamic landscape of multimodal cancer care is boosting demand for oncology-specific technological innovations. The need for elevated cancer care is steadily climbing, compelling software developers to create increasingly integrated and sophisticated solutions. Oncology has always been at the forefront of digitization due to the substantial amount of data needed and generated for each patient during the treatment process. Today, advanced oncology software offers clinicians a
Read More
PicnicHealth Enters Oncology Real-World Data Market
What You Should Know: PicnicHealth, a patient-centered health technology company, today announced its entry into the real-world data market for oncology.Drawing from its success working with chronic disease patients to create robust datasets, the company aims to advance oncology research using a similar model by working directly with people living with cancer to collect and structure their medical records data. PicnicHealth is actively exploring partnerships to develop new patient
Read More
